Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Caer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|May 24, 2005
[High-dose buprenorphine substitution during incarceration.]Catherine Reynaud-Maurupt, Yves Caer, Noëlle Escaffre, et al.
Presse Medicale (Paris, France : 1983)|May 21, 2005
[High-dose buprenorphine substitution during incarceration. Management of opiate addicts]Catherine Revnaud-Maurupt, Yves Caer, Noëlle Escaffre, et al.
Journal of Substance Abuse Treatment|October 6, 2009
Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter studyJean-Pierre Daulouède, Yves Caer, Pascal Galland, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|May 24, 2005
[High-dose buprenorphine substitution during incarceration.]Catherine Reynaud-Maurupt, Yves Caer, Noëlle Escaffre, et al.
Presse Medicale (Paris, France : 1983)|May 21, 2005
[High-dose buprenorphine substitution during incarceration. Management of opiate addicts]Catherine Revnaud-Maurupt, Yves Caer, Noëlle Escaffre, et al.
Journal of Substance Abuse Treatment|October 6, 2009
Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter studyJean-Pierre Daulouède, Yves Caer, Pascal Galland, et al.
Pageof 1